TSH-рroducing pituitary microadenoma: diagnostic problems in the debut of the disease
https://doi.org/10.14341/probl12860
Abstract
Tumors of the pituitary gland producing thyrotropin hormone (TSH) are rare and account for about 1–3% of all pituitary adenomas, most frequently occurring in persons of young and working age. This article presents a clinical case of thyrotropinoma in a 44-year-old woman, which was diagnosed 6 years after her initial visit to an endocrinologist. At the debut of the disease, thyrotropinoma manifested as an isolated elevation of TSH, with normal levels of free T4 and free T3. The patient was constantly taking β-blockers due to her disturbing tachycardia. She was diagnosed with subclinical hypothyroidism, for which she was periodically observed, controlling her TSH level and taking levothyroxine drugs in a dose of up to 175 mcg, which was accompanied by elevated TSH levels. After 6 years, there was an increase in free T3 and free T4 in addition to TSH. Magnetic resonance imaging with intravenous contrast enhancement revealed a pituitary microadenoma 4 mm in size, and laboratory examination of all tropic hormones revealed an isolated increase in TSH. Transsphenoidal adenomectomy was performed at the diagnosis of TSH-producing pituitary adenoma. During the three-year postoperative follow-up there was no adenoma recurrence, secondary hypothyroidism developed, the patient currently takes levothyroxine 75 mcg per day continuously
About the Authors
A. V. KlimchukRussian Federation
Anastasia V. Klimchuk, PhD
295051, Lenin boulevard 5/7, Simferopol
I. A. Yatskov
Russian Federation
Igor A. Yatskov
295051, Lenin boulevard 5/7, Simferopol
K. V. Bubley
Russian Federation
Konstantin V. Bubley
295051, Lenin boulevard 5/7, Simferopol
D. A. Enzel
Russian Federation
Darya A. Enzel
295051, Lenin boulevard 5/7, Simferopol
A. S. Sherbakov
Russian Federation
Akim S. Sherbakov
295051, Lenin boulevard 5/7, Simferopol
References
1. Kalinin PL, Fomichev DV, Kutin MA, et al. Endoscopic endonasal surgery of pituitary adenomas (experience of 1700 operations). Zhurnal «Voprosy nejrohirurgii» imeni N.N. Burdenko. 2012;76(3):26-33. (In Russ.).
2. Kalinin PL, Kadashev BA, Fomichev DV, et al. Clinical guidelines «surgical treatment of pituitary adenoma». Moscow: Research Institute of Neurosurgery. acad. N.N. Burdenko; 2014. (In Russ.).
3. Aflorei ED, Korbonits M. Epidemiology and etiopathogenesis of pituitary adenomas. J Neurooncol. 2014;117(3):379-394. doi: https://doi.org/10.1007/s11060-013-1354-5
4. Önnestam L, Berinder K, Burman P, et al. National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden. J Clin Endocrinol Metab. 2013;98(2):626-635. doi: https://doi.org/10.1210/jc.2012-3362
5. Fernandez A, Karavitaki N, Wass JAH. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf ). 2010;72(3):377-382. doi: https://doi.org/10.1111/j.1365-2265.2009.03667.x
6. Astaf’eva LI, Kadashev BA, Shishkina LV, et al. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas. Zhurnal Voprosy Neirokhirurgii Imeni N.N. Burdenko. 2016;80(6):24-35. (In Russ.)]. doi: https://doi.org/10.17116/neiro201680624-35
7. Yamada S, Fukuhara N, Horiguchi K, et al. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg. 2014;121(6):1462-1473. doi: https://doi.org/10.3171/2014.7.JNS1471
8. Przhialkovskaya EG, Gazizova DO, Grigoriev AYu, et al. Thyrotropinproducing adenoma: diagnostic challenges (Сase report).. Clinical and experimental thyroidology. 2011;7(2):68-73. (In Russ.).
9. Wang EL, Qian ZR, Yamada S, et al. Clinicopathological characterization of TSH-producing adenomas: special reference to TSH immunoreactive but clinically nonfunctioning adenomas. Endocr Pathol. 2009;20(4):209-220. doi: https://doi.org/10.1007/s12022-009-9094-y
10. Beck-Peccoz P, Lania A, Persani L. TSH-producing adenomas. In: Jameson JL, Degroot LJ, editors. Endocrinology. 7th ed. USA: W.B. Saunders Pub.; 2015.
11. Arimura H, Askoro R, Fujio S, et al. A Thyroid-stimulating Hormone (TSH) Producing Adenoma in a Patient with Severe Hypothyroidism: Thyroxine Replacement Reduced the TSH Level and Tumor Size. NMC Case Report J. 2020;7(1):17-21. doi: https://doi.org/10.2176/nmccrj.cr.2018-0323
12. Beck-Peccoz P, Lania A, Beckers A, et al. 2013 European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J. 2013;2(2):76-82. doi: https://doi.org/10.1159/000351007
13. Fadeyev VV. Review of European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumours. Clinical and experimental thyroidology. 2016;12(4):39-45. (In Russ.). doi: https://doi.org/10.14341/ket2016439-45
14. Molitch ME. Diagnosis and treatment of pituitary adenomas: A review. JAMA. 2017;317(5):516-524. doi: https://doi.org/10.1001/jama.2016.19699
15. Petrik GG, Kosmacheva ED, Polyakova YuI, et al. TSH-secreting pituitary adenoma: late diagnosis and effectiveness of therapy. Problems of Endocrinology. 2017;63(1):39-45. (In Russ.). doi: https://doi.org/10.14341/probl201763139-45
16. Malchiodi E, Profka E, Ferrante E, et al. Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation. J Clin Endocrinol Metab. 2014;99(6):2069-2076. doi: https://doi.org/10.1210/jc.2013-4376
Supplementary files
|
1. Рисунок 1. Магнитно-резонансная томография хиазмально-селлярной области. Выделена микроаденома гипофиза. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(348KB)
|
Indexing metadata ▾ |
Review
For citations:
Klimchuk A.V., Yatskov I.A., Bubley K.V., Enzel D.A., Sherbakov A.S. TSH-рroducing pituitary microadenoma: diagnostic problems in the debut of the disease. Problems of Endocrinology. 2022;68(3):44-49. (In Russ.) https://doi.org/10.14341/probl12860

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).